2nd Quarter - Report

VAN FLEET ASSOCIATES for BELLUS MEDICAL

Period 2nd Quarter 2016 Filed Jul 14, 2016 Signed by walter sanders

Official filing
Firm
VAN FLEET ASSOCIATES
Client
BELLUS MEDICAL
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

Requesting the FDA to approve a submission to create a Class II medical device protocol for the microneedling industry.

LobbyistCovered position, as disclosed
WALTER SANDERS —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Gain approval of specific medical technologies (microneedling) regulated by the Federal Food and Drug Administration.

LobbyistCovered position, as disclosed
WALTER SANDERS —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.